Inhaled metaproterenol is superior to inhaled cromolyn in protecting against cold-air-induced bronchospasm. 1988

R H Israel, and J M Kohan, and R H Poe, and M C Kallay, and D W Greenblatt, and S Rathbun
Pulmonary Units of St. Mary's Hospital, Rochester, N.Y.

Eucapneic hyperventilation of cold air (EHCA) provokes bronchospasm in asthmatics. Although inhaled cromolyn powder and sympathomimetic solutions have attenuated the bronchospasm induced by EHCA, comparison of both drugs in solution has not been performed. We performed a prospective double-blind study comparing cromolyn solution, metaproterenol solution, and placebo (normal saline) given prior to EHCA. Eight asthmatics defined by a 20% reduction in forced expiratory volume in 1s (FEV1) after EHCA consented to the study. Patients were tested on 3 separate occasions at a similar time of day. Each session began with a determination of FEV1 followed by a randomized double-blind treatment. A repeat FEV1 (pre-EHCA) was performed 20 min after drug inhalation. Twelve minutes of EHCA was performed consisting of 4 min of tidal breathing, 4 min of eucapneic hyperventilation (60-70% of the predicted MVV) and a final 4 min of tidal breathing. FEV1 was performed immediately, 5 min, and 10 min after EHCA. The lowest value was defined as the post-EHCA FEV1. The pre-EHCA FEV1 was significantly larger after metaproterenol pretreatment compared to the pre-EHCA FEV1 following cromolyn (p = 0.01) and saline (p = 0.04). Metaproterenol pretreatment had a significant protective effect in comparison to placebo pretreatment (p less than 0.01). No other paired comparisons (cromolyn vs. placebo, cromolyn vs. metaproterenol) achieved statistical significance at a 0.05 level. In conclusion, metaproterenol is superior to cromolyn in protecting against cold-air-induced bronchospasm.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009921 Metaproterenol A beta-2 adrenergic agonist used in the treatment of ASTHMA and BRONCHIAL SPASM. Orciprenaline,Alotec,Alupent,Astmopent,Metaprel,Metaproterenol Polistirex,Metaproterenol Sulfate,Orciprenaline Sulfate,Polistirex, Metaproterenol
D001986 Bronchial Spasm Spasmodic contraction of the smooth muscle of the bronchi. Bronchospasm,Bronchial Spasms,Bronchospasms,Spasm, Bronchial,Spasms, Bronchial
D003080 Cold Temperature An absence of warmth or heat or a temperature notably below an accustomed norm. Cold,Cold Temperatures,Temperature, Cold,Temperatures, Cold
D004205 Cromolyn Sodium A chromone complex that acts by inhibiting the release of chemical mediators from sensitized MAST CELLS. It is used in the prophylactic treatment of both allergic and exercise-induced asthma, but does not affect an established asthmatic attack. Disodium Cromoglycate,Sodium Cromoglycate,Aarane,Bicromat Spray,Cromoglicic Acid,Cromoglycate,Cromoglycic Acid,Cromolyn,FPL-670,Intal,Lomudal,Nalcrom,Nasalcrom,Opticrom,Vicrom,Acid, Cromoglicic,Acid, Cromoglycic,Cromoglycate, Disodium,Cromoglycate, Sodium,FPL 670,FPL670
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000280 Administration, Inhalation The administration of drugs by the respiratory route. It includes insufflation into the respiratory tract. Drug Administration, Inhalation,Drug Administration, Respiratory,Drug Aerosol Therapy,Inhalation Drug Administration,Inhalation of Drugs,Respiratory Drug Administration,Aerosol Drug Therapy,Aerosol Therapy, Drug,Drug Therapy, Aerosol,Inhalation Administration,Administration, Inhalation Drug,Administration, Respiratory Drug,Therapy, Aerosol Drug,Therapy, Drug Aerosol
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

R H Israel, and J M Kohan, and R H Poe, and M C Kallay, and D W Greenblatt, and S Rathbun
May 1968, Annals of allergy,
R H Israel, and J M Kohan, and R H Poe, and M C Kallay, and D W Greenblatt, and S Rathbun
February 1992, Archives of disease in childhood,
R H Israel, and J M Kohan, and R H Poe, and M C Kallay, and D W Greenblatt, and S Rathbun
August 1987, Annals of allergy,
R H Israel, and J M Kohan, and R H Poe, and M C Kallay, and D W Greenblatt, and S Rathbun
April 1969, Annals of allergy,
R H Israel, and J M Kohan, and R H Poe, and M C Kallay, and D W Greenblatt, and S Rathbun
April 1989, Annals of allergy,
R H Israel, and J M Kohan, and R H Poe, and M C Kallay, and D W Greenblatt, and S Rathbun
July 1986, Journal of applied physiology (Bethesda, Md. : 1985),
R H Israel, and J M Kohan, and R H Poe, and M C Kallay, and D W Greenblatt, and S Rathbun
December 1994, American journal of respiratory and critical care medicine,
R H Israel, and J M Kohan, and R H Poe, and M C Kallay, and D W Greenblatt, and S Rathbun
November 1975, Pediatrics,
R H Israel, and J M Kohan, and R H Poe, and M C Kallay, and D W Greenblatt, and S Rathbun
January 1996, Prehospital and disaster medicine,
R H Israel, and J M Kohan, and R H Poe, and M C Kallay, and D W Greenblatt, and S Rathbun
August 1978, Journal of applied physiology: respiratory, environmental and exercise physiology,
Copied contents to your clipboard!